Abstract
Rats treated with lithium chloride for 6 weeks have been reported to demonstrate reduced turnover of arachidonic acid (AA) in brain phospholipids, and decreases in mRNA and protein levels, and enzyme activity, of AA-selective cytosolic phospholipase A2(cPLA2). We now report that chronic lithium administration to rats significantly reduced the brain protein level and enzyme activity of cyclooxygenase-2 (COX-2), without affecting COX-2 mRNA. Lithium also reduced the brain concentration of prostaglandin E2 (PGE2), a bioactive product of AA formed via the COX reaction. COX-1 and the Ca2+-independent iPLA2 (type VI) were unaffected by lithium. These and prior results indicate that lithium targets a part of the AA cascade that involves cPLA2 and COX-2. This effect may contribute to lithium's therapeutic action in bipolar disorder.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cade JFJ . Lithium salts in the treatment of psychotic excitement Med J Austral 1949; 36: 349–352
Manji HK, Potter WZ, Lenox RH . Signal transduction pathways. Molecular targets for lithium's action Arch Gen Psychiatry 1995; 52: 531–543
Jope RS . Anti-bipolar therapy: mechanism of action of lithium Mol Psychiatry 1999; 4: 117–128
Phiel CJ, Klein PS . Molecular targets of lithium action Annu Rev Pharmacol Toxicol 2001; 41: 789–813
Chen RW, Chuang DM . Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J Biol Chem 1999; 274: 6039–6042
Axelrod J . Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction Biochem Soc Trans 1990; 18: 503–507
Reddy ST, Herschman HR . Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells J Biol Chem 1997; 272: 3231–3237
Fitzpatrick FA, Soberman R . Regulated formation of eicosanoids J Clin Invest 2001; 107: 1347–1351
Horrobin DF, Manku MS . Possible role of prostaglandin E1 in the affective disorders and in alcoholism Br Med J 1980; 280: 1363–1366
Karmazyn M, Manku MS, Horrobin DF . Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins Endocrinology 1978; 102: 1230–1236
Farooqui AA, Horrocks LA, Farooqui T . Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders Chem Phys Lipids 2000; 106: 1–29
Brash AR . Arachidonic acid as a bioactive molecule J Clin Invest 2001; 107: 1339–1345
Wolfe LS, Horrocks LA . Eicosanoids In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic Neurochemistry, 5th edn Raven Press: New York 1994; pp 475–490
Chang MC, Grange E, Rabin O, Bell JM, Rapoport SI . Lithium decreases turnover of arachidonate in several phospholipids Neurosci Lett 1996; 220: 171–174
Chang MC, Bell JM, Purdon AD, Chikhale EG, Grange E . Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment Neurochem Res 1999; 24: 399–406
Chang MC, Jones CR . Chronic lithium treatment decreases brain phospholipase A2 activity Neurochem Res 1998; 23: 887–892
Rintala J, Seemann R, Chandrasekaran K, Rosenberger TA, Chang L, Contreras MA et al. 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain Neuroreport 1999; 10: 3887–3890
Herschman HR . Prostaglandin synthase 2 Biochim Biophys Acta 1996; 1299: 125–140
Smith WL, Garavito DL, DeWitt DL . Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 J Biol Chem 1996; 271: 33157–33160
Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P . COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc Natl Acad Sci USA 1996; 93: 2317–2321
Niwa K, Araki E, Morham SG, Ross ME, Iadecola C . Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex J Neurosci 2000; 20: 763–770
Yamamoto T, Nozaki-Taguchi N . Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor Brain Res 1996; 739: 104–110
Frank E, Swartz HA, Kupfer DJ . Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder Biol Psychiatry 2000; 48: 430–432
Martinez FE, Harabor A, Amankwah EK, Hart DA, Belik J . Urethane suppresses rat lung inducible cyclooxygenase and nitric oxide synthase mRNA levels Inflamm Res 2000; 49: 727–731
Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB . Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide J Clin Invest 1995; 95: 1669–1675
Powell WS . Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases Anal Biochem 1985; 148: 59–69
Taniguchi Y, Yokoyama K, Inui K, Deguchi Y, Furukawa K, Noda K . Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide Eur J Pharmacol 1997; 330: 221–229
Bosetti F, Seemann R, Bell JM, Zahorchak R, Friedman E, Rapoport SI et al. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration Brain Res Bull 2002; 57: 205–209
Furth EE, Hurtubise V, Schott MA, Laposata M . The effect of endogenous essential and nonessential fatty acids on the uptake and subsequent agonist-induced release of arachidonate J Biol Chem 1989; 264: 18494–18501
Morita L, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2 J Biol Chem 1995; 270: 10902–10908
Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K . Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers Genomics 1995; 26: 138–141
Chang MC, Contreras MA, Rosenberger TA, Rintala JJ, Bell JM, Rapoport SI . Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers J Neurochem 2001; 77: 796–803
Szupera Z, Mezei Z, Kis B, Gecse A, Vecsei L, Telegdy G . The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets Eur J Pharmacol 2000; 387: 205–210
Verburg KM, Maziasz TJ, Weiner E, Loose L, Geis GS, Isakson PC . COX-2 specific inhibitors: definition of a new therapeutic concept Am J Ther 2001; 8: 49–64
Ketterer MW, Brymer J, Rhoads K, Kraft P, Lovallo WR . Is aspirin, as used for antithrombosis, an emotion-modulating agent? J Psychosom Res 1996; 40: 53–58
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR . TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 1991; 266: 12866–12872
Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM . Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′ untranslated region J Biol Chem 2000; 275: 11750–11757
Hla T, Neilson K . Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 1992; 89: 7384–7388
Faour WH, He Y, He QW, de Ladurantaye M, Quintero M, Mancini A et al. Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen activated protein kinase in interleukin-1β-treated human synovial fibroblasts J Biol Chem 2001; 34: 31720–31731
Horrobin DF, Mtabaji JP, Manku MS, Karmazyn M . Lithium as a regulator of hormone-stimulated prostaglandin synthesis In: Johnson FN, Johnson S (eds) Lithium in Medical Practice University Park Press: Baltimore MD 1978; pp 243–246
Dawson E, Gill M, Curtis D, Castle D, Hunt N, Murray R et al. Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder Psychiatr Genet 1995; 5: 177–180
Jacobsen NJ, Franks EK, Owen MJ, Craddock NJ . Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder Mol Psychiatry 1999; 4: 274–279
Hayaishi O . Prostaglandin D2 and sleep—a molecular genetic approach J Sleep Res 1999; 8: 60–64
Yoshida Y, Matsumura H, Nakajima T, Mandai M, Urakami T, Kuroda K et al. Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2 Neuroreport 2000; 11: 2127–2131
Hayaishi O . Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2 Philos Trans R Soc Lond B Biol Sci 2000; 355: 275–280
Matsumura H, Honda K, Choi WS, Inoue S, Sakai T, Hayaishi O . Evidence that brain prostaglandin E2 is involved in physiological sleep-wake regulation in rats Proc Natl Acad Sci USA 1989; 86: 5666–5669
Horrobin DF, Lieb J . A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system Med Hypotheses 1981; 7: 891–905
Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial Arch Gen Psychiatry 1999; 56: 407–412
Noaghiul S, Hibbeln JR, Weissman MM . Cross-national comparisons of seafood consumption and rates of bipolar disorder Am J Psychiatry (in press)
Corey EJ, Shih C, Cashman JR . Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis Proc Natl Acad Sci USA 1983; 80: 3581–3584
Rubin D, Laposata M . Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation/desaturation, distribution among complex lipids, and conversion to eicosanoids J Lipid Res 1992; 33: 1431–1440
Seung Kim HF, Weeber EJ, Sweatt JD, Stoll AL, Marengell LB . Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro Mol Psychiatry 2001; 6: 246–248
Acknowledgements
The authors wish to thank Professor Harvey Herschman for his critical review of this manuscript and Jane Bell for technical help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bosetti, F., Rintala, J., Seemann, R. et al. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain. Mol Psychiatry 7, 845–850 (2002). https://doi.org/10.1038/sj.mp.4001111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001111
Keywords
This article is cited by
-
Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder
Scientific Reports (2016)
-
Chronic Lithium Feeding Reduces Upregulated Brain Arachidonic Acid Metabolism in HIV-1 Transgenic Rat
Journal of Neuroimmune Pharmacology (2012)
-
Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder?
Molecular Psychiatry (2010)
-
Resveratrol inhibits prostaglandin formation in IL-1β-stimulated SK-N-SH neuronal cells
Journal of Neuroinflammation (2009)
-
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder
Molecular Psychiatry (2009)